Dr. med.
Petra Hoppmann
Oberärztin
+49 (0)89 4140 2947
Dr. med.
Alessandra Buiatti
Funktionsoberärztin

Forschung Elektrophysiologie

Veröffentlichungen :


 Association of Toll-like receptor 4 polymorphism with age-dependent systolic blood pressure increase in patients with coronary artery disease.

Schneider S, Koch W, Hoppmann P, Ubrich R, Kemmner S, Steinlechner E, Heemann U, Laugwitz KL, Kastrati A, Baumann M.

Immun Ageing. 2015 May 20;12:4. doi: 10.1186/s12979-015-0031-2. eCollection 2015.


Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.

Kufner S, Cassese S, Valeskini M, Neumann FJ, Schulz-Schüpke S, Hoppmann P, Fusaro M, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA; ISAR-DESIRE 3 Investigators.

JACC Cardiovasc Interv. 2015 Jun;8(7):877-84. doi: 10.1016/j.jcin.2015.01.031. Epub 2015 May 20.


The impact of therapeutic hypothermia on on-treatment platelet reactivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry.

Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, Mehilli J, Schunkert H, Massberg S, Laugwitz KL, Sibbing D, Kastrati A.

Thromb Res. 2015 Jul;136(1):87-93. doi: 10.1016/j.thromres.2015.04.029. Epub 2015 Apr 30.


Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial.

Fiedler KA, Maeng M, Mehilli J, Schulz-Schüpke S, Byrne RA, Sibbing D, Hoppmann P, Schneider S, Fusaro M, Ott I, Kristensen SD, Ibrahim T, Massberg S, Schunkert H, Laugwitz KL, Kastrati A, Sarafoff N.

J Am Coll Cardiol. 2015 Apr 28;65(16):1619-29. doi: 10.1016/j.jacc.2015.02.050.


.Impact of inhospital stent thrombosis and cerebrovascular accidents on long-term prognosis after percutaneous coronary intervention.

Guerra E, Ndrepepa G, Schulz S, Byrne R, Hoppmann P, Kufner S, Ibrahim T, Tada T, Schunkert H, Laugwitz KL, Kastrati A.

Am Heart J. 2014 Dec;168(6):862-8.e1. doi: 10.1016/j.ahj.2014.08.015. Epub 2014 Sep 16.


Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial.

Kufner S, Byrne RA, Valeskini M, Schulz S, Ibrahim T, Hoppmann P, Schneider S, Laugwitz KL, Schunkert H, Kastrati A.

EuroIntervention. 2014 Nov 9. pii: 20140422-06. doi: 10.4244/EIJY14M11_02. [Epub ahead of print]


Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.

Schulz-Schüpke S, Helde S, Gewalt S, Ibrahim T, Linhardt M, Haas K, Hoppe K, Böttiger C, Groha P, Bradaric C, Schmidt R, Bott-Flügel L, Ott I, Goedel J, Byrne RA, Schneider S, Burgdorf C, Morath T, Kufner S, Joner M, Cassese S, Hoppmann P, Hengstenberg C, Pache J, Fusaro M, Massberg S, Mehilli J, Schunkert H, Laugwitz KL, Kastrati A; Instrumental Sealing of Arterial Puncture Site—CLOSURE Device vs Manual Compression (ISAR-CLOSURE) Trial Investigators.

JAMA. 2014 Nov 19;312(19):1981-7. doi: 10.1001/jama.2014.15305.

Prasugrelvs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry.

Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, Mehilli J, Schunkert H, Massberg S, Laugwitz KL, Sibbing D, Kastrati A.

Thromb Haemost. 2014 Dec;112(6):1190-7. doi: 10.1160/TH14-06-0489. Epub 2014 Aug 28.


Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry.

Mayer K, Bernlochner I, Braun S, Schulz S, Orban M, Morath T, Cala L, Hoppmann P, Schunkert H, Laugwitz KL, Kastrati A, Sibbing D.

J Am Coll Cardiol. 2014 Sep 2;64(9):863-71. doi: 10.1016/j.jacc.2014.05.049.


Genetic risk of restenosis after percutaneous coronary interventions in the era of drug-eluting stents.

Hoppmann P, Koch W, Laugwitz KL, Kastrati A.

Coron Artery Dis. 2014 Dec;25(8):658-64. doi: 10.1097/MCA.0000000000000149.


Clinical outcomes of patients treated with Nobori biolimus-eluting stent: Meta-analysis of randomized trials.

Cassese S, Fusaro M, Byrne RA, Tada T, Hoppmann P, Joner M, Laugwitz KL, Schunkert H, Kastrati A.

Int J Cardiol. 2014 Aug 20;175(3):484-91. doi: 10.1016/j.ijcard.2014.06.014. Epub 2014 Jun 28.


Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction.

Schulz S, Richardt G, Laugwitz KL, Morath T, Neudecker J, Hoppmann P, Mehran R, Gershlick AH, Tölg R, Anette Fiedler K, Abdel-Wahab M, Kufner S, Schneider S, Schunkert H, Ibrahim T, Mehilli J, Kastrati A; Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Investigators.

Eur Heart J. 2014 Sep 7;35(34):2285-94. doi: 10.1093/eurheartj/ehu182. Epub 2014 May 9.


Correlates of poor outcome among patients with bleeding after coronary interventions.

Ndrepepa G, Guerra E, Schulz S, Hoppmann P, Laugwitz KL, Kastrati A.

Coron Artery Dis. 2014 Sep;25(6):456-62. doi: 10.1097/MCA.0000000000000126.


Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy.

Ndrepepa G, Schulz S, Neumann FJ, Byrne RA, Hoppmann P, Cassese S, Ott I, Fusaro M, Ibrahim T, Tada T, Richardt G, Laugwitz KL, Schunkert H, Kastrati A.

Am Heart J. 2013 Sep;166(3):534-40. doi: 10.1016/j.ahj.2013.07.006. Epub 2013 Aug 6.


The chromosome 9p21 region and myocardial infarction in a European population.

Koch W, Türk S, Erl A, Hoppmann P, Pfeufer A, King L, Schömig A, Kastrati A.

Atherosclerosis. 2011 Jul;217(1):220-6. doi: 10.1016/j.atherosclerosis.2011.03.014. Epub 2011 Mar 24.


4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries.

Koch W, Schrempf M, Erl A, Mueller JC, Hoppmann P, Schömig A, Kastrati A.

Thromb Haemost. 2010 Jun;103(6):1170-80. doi: 10.1160/TH09-10-0702. Epub 2010 Mar 29.


Mapping of atrial tachycardia by remote magnetic navigation in postoperative patients with congenital heart disease.

Wu J, Pflaumer A, Deisenhofer I, Hoppmann P, Hess J, Hessling G.

J Cardiovasc Electrophysiol. 2010 Jul;21(7):751-9. doi: 10.1111/j.1540-8167.2009.01697.x. Epub 2010 Feb 1.


No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents.

Hoppmann P, Erl A, Türk S, Tiroch K, Mehilli J, Schömig A, Kastrati A, Koch W.

JACC Cardiovasc Interv. 2009 Nov;2(11):1149-55. doi: 10.1016/j.jcin.2009.08.021.


Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: case-control study and a meta-analysis.

Koch W, de Waha A, Hoppmann P, Schömig A, Kastrati A.

Atherosclerosis. 2010 Jan;208(1):171-6. doi: 10.1016/j.atherosclerosis.2009.08.021. Epub 2009 Aug 19.


Variations of specific non-candidate genes and risk of myocardial infarction: a replication study.

Koch W, Hoppmann P, Schömig A, Kastrati A.

Int J Cardiol. 2011 Feb 17;147(1):38-41. doi: 10.1016/j.ijcard.2009.07.028. Epub 2009 Aug 25.


News

Newsfeeds abonnieren